Clinical Characteristics of Infantile Hemangioma

Launched by WEST CHINA HOSPITAL · Oct 31, 2017

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the characteristics of a condition called infantile hemangioma (IH), which is a common type of birthmark that usually appears as a raised, red area on the skin in babies. The study aims to gather information about how IH presents in children, especially looking at cases where the hemangioma affects the liver (called infantile hepatic hemangioma) and instances where the hemangioma breaks down the skin (ulceration). By collecting this information, researchers hope to improve the care and treatment options for children with IH.

To be eligible for this study, children must be 6 years old or younger and diagnosed with infantile hemangioma. Both parents or guardians need to agree to participate. However, children with other types of vascular growths or those who have already received specific treatments for hemangiomas are not eligible. If a child joins the trial, their doctors will monitor their condition closely and gather important data, which could help in understanding this condition better in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≤6 years old
• • Diagnose of IHs
• • Consent of both parents (or the person having parental authority in families)
• Exclusion Criteria:
• • Congenital hemangioma, kaposiform hemangioendothelioma, or other vascular anomalies
• • Age\>6 years
• • Hemangioma has been previous treated with corticosteroids, laser, cryotherapy, or only other treatments
• • Patients with an inability to participate or to follow the study treatment and assessment plan